Keynotes

Wednesday, November 4

Opportunities & Challenges for
Science and Innovation in 2021
10:00 AM

Collaboration in the COVID Crisis:
How Unprecedented Partnerships are Accelerating Successful Vaccines and Therapeutics
12:30 PM

Dr. Michelle McMurry-Heath

President & CEO, Biotechnology Innovation Organization (BIO)

Maria Thacker-Goethe

President & CEO, Georgia Bio;
CEO, Center for Global Health Innovation

Dr. Paul Burton

Chief Global Medical Affairs Officer, Janssen Pharmaceuticals

Dr. Alejandro Cané

VP, U.S. Medical and Scientific Affairs Lead, Pfizer Vaccines

Danica Dilligard

Partner, EY

Dr. Clement Lewis

Associate Vice President Head BARDA Office & NV Stakeholder Engagement,
Sanofi Pasteur

Thursday, November 5

Devices & Data: Impacts on
the Healthcare Continuum

9:30 AM

Becoming Better Ancestors: Lessons
from Past Successes in Disease Eradication
11:15 AM

Ken Berta

Executive Director, Global Health Crisis Coordination Center

Dan Brady

Business Leader for Connected Care, Philips

Steven Lazer

Global Healthcare CTO,
Dell Technologies Healthcare and Life Sciences

Patty Obermaier

Vice President, US Health and Life Sciences, Microsoft

Dr. Seth Berkley

CEO, Gavi, the Vaccine Alliance;

Founder & past President and CEO of the International AIDS Vaccine Initiative (IAVI)

Dr. William Foege

Emory Presidential Distinguished Professor of Global Health Emeritus; Director, Centers for Disease Control & Prevention, 1977-1983; Director, The Carter Center, 1986-1992; Founder, Task Force for Global Health; Senior Fellow, Bill & Melinda Gates Foundation; Co-Chair, NASEM committee developing Framework for Equitable Allocation of a COVID-19 Vaccine

Dr. Helene Gayle

President & CEO, The Chicago Community Trust; Co-Chair, NASEM committee developing Framework for Equitable Allocation of a COVID-19 Vaccine; President & CEO, CARE, 2006-2015; CEO, McKinsey Social Initiative, 2015-2017